Vous êtes ici : Accueil / Publications / Articles dans des revues à comité de lecture / 2022

2022

Landman R., de Truchis P., Assoumou L., Lambert S., Bellet J., Amat K., Lefebvre B., Allavena C., Katlama C., Yazdanpanah Y., Molina J.-M., Petrov-Sanchez V., Gibowski S., Alvarez J. C., Leibowitch J., Capeau J., Fellahi S., Duracinsky M., Morand-Joubert L., Costagliola D., Alvarez J.-C., Girard P.-M., et ANRS 170 QUATUOR study group,
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial,
Lancet HIV, vol. 9, no 2, p. e79‑e90, févr. 2022. doi: 10.1016/S2352-3018(21)00300-3.

Nkuba-Ndaye A., Mukadi-Bamuleka D., Bulabula-Penge J., Thaurignac G., Edidi-Atani F., Mambu-Mbika F., Danga-Yema B., Matondo-Kuamfumu M., Kinganda-Lusamaki E., Bisento N., Lumembe-Numbi R., Kabamba-Lungenyi G., Kitsa-Mutsumbirwa D., Kambale-Sivihwa N., Boillot F., Delaporte E., Mbala-Kingebeni P., Ayouba A., Peeters M., et Ahuka-Mundeke S.,
Added value of an anti-Ebola serology for the management of clinically suspect Ebola virus disease patients discharged as negative in an epidemic context,
J Infect Dis, p. jiac057, févr. 2022. doi: 10.1093/infdis/jiac057.

Campillo J. T., Eiden C., Boussinesq M., Pion S. D. S., Faillie J.-L., et Chesnais C. B.,
Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study,
Br J Clin Pharmacol, vol. 88, no 3, p. 1094‑1106, mars 2022. doi: 10.1111/bcp.15037.

Butler M. S., Gigante V., Sati H., Paulin S., Al-Sulaiman L., Rex J. H., Fernandes P., Arias C. A., Paul M., Thwaites G. E., Czaplewski L., Alm R. A., Lienhardt C., Spigelman M., Silver L. L., Ohmagari N., Kozlov R., Harbarth S., et Beyer P.,
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed,
Antimicrob Agents Chemother, p. AAC0199121, janv. 2022. doi: 10.1128/AAC.01991-21.

Kochhar S., Barreira D., Beattie P., Cavaleri M., Cravioto A., Frick M. W., Ginsberg A. M., Hudson I., Kaslow D. C., Kurtz S., Lienhardt C., Madhi S. A., Morgan C., Momeni Y., Patel D., Rees H., Rogalski-Salter T., Schmidt A., Semete-Makokotlela B., Voss G., White R. G., Zignol M., et Giersing B.,
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case ,
Vaccine, vol. 40, no 12, p. 1681‑1690, mars 2022. doi: 10.1016/j.vaccine.2021.10.062.

Moh D. R., Bangali M., Coffie P., Badjé A., Paul A. A., et Msellati P.,Community Health Workers.
Reinforcement of an Outreach Strategy in Rural Areas Aimed at Improving the Integration of HIV, Tuberculosis and Malaria Prevention, Screening and Care Into the Health Systems. « Proxy-Santé » Study,
Front Public Health, vol. 10, p. 801762, 2022. doi: 10.3389/fpubh.2022.801762.

Rabilloud M., Riche B., Etard J. F., Elsensohn M.-H., Voirin N., Bénet T., Iwaz J., Ecochard R., et Vanhems P.,
COVID-19 outbreaks in nursing homes: A strong link with the coronavirus spread in the surrounding population, France, March to July 2020 ,
PLoS One, vol. 17, no 1, p. e0261756, 2022. doi: 10.1371/journal.pone.0261756.

Yaya I., Diallo F., Kouamé M. J.-B., Agboyibor M. K., Traoré I., Coulibaly A., Maiga K., Mora M., Palvadeau P., Dah E. T. T., Mensah E., Anoma C., Dembélé Keita B., Spire B., Laurent C., et CohMSM Study Group,
Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France),
Sex Transm Infect, vol. 98, no 2, p. 85‑94, mars 2022. doi: 10.1136/sextrans-2020-054755.

Wobudeya E., Bonnet M., Walters E. G., Nabeta P., Song R., Murithi W., Mchembere W., Dim B., Taguebue J.-V., Orne-Gliemann J., Nicol M. P., et Marcy O.,
Diagnostic Advances in Childhood Tuberculosis-Improving Specimen Collection and Yield of Microbiological Diagnosis for Intrathoracic Tuberculosis,
Pathogens, vol. 11, no 4, p. 389, mars 2022. doi: 10.3390/pathogens11040389.

Djomsi D. M., Mba Djonzo F. A., Ndong Bass I., Champagne M., Lacroix A., Thaurignac G., Esteban A., De Nys H., Bourgarel M., Akoachere J.-F., Delaporte E., Ayouba A., Cappelle J., Mpoudi Ngole E., et Peeters M.,
Dynamics of Antibodies to Ebolaviruses in an Eidolon helvum Bat Colony in Cameroon,
Viruses, vol. 14, no 3, p. 560, mars 2022. doi: 10.3390/v14030560.

Diallo A., Carlos-Bolumbu M., Diallo M. H., Makinson A., et Galtier F.,
Efficacy of approved vaccines to prevent COVID-19: a systematic review and network meta-analysis of reconstructed individual patient data from randomized trials,
Z Gesundh Wiss, p. 1‑10, mars 2022. doi: 10.1007/s10389-022-01707-1.

Bedin A.-S., Makinson A., Picot M.-C., Mennechet F., Malergue F., Pisoni A., Nyiramigisha E., Montagnier L., Bollore K., Debiesse S., Morquin D., Bourgoin P., Veyrenche N., Renault C., Foulongne V., Bret C., Bourdin A., Le Moing V., Van de Perre P., et Tuaillon E.,
Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019,
J Infect Dis, vol. 225, no 4, p. 744, févr. 2022. doi: 10.1093/infdis/jiab599.

Vasiliu A., Tiendrebeogo G., Awolu M. M., Akatukwasa C., Tchakounte B. Y., Ssekyanzi B., Tchounga B. K., Atwine D., Casenghi M., Bonnet M., et CONTACT study group,
Feasibility of a randomized clinical trial evaluating a community intervention for household tuberculosis child contact management in Cameroon and Uganda ,
Pilot Feasibility Stud, vol. 8, no 1, p. 39, févr. 2022. doi: 10.1186/s40814-022-00996-3.

WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group,
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data ,
BMC Med, vol. 20, no 1, p. 85, mars 2022. doi: 10.1186/s12916-022-02265-9.

Soumah A. A., Diallo M. S. K., Guichet E., Maman D., Thaurignac G., Keita A. K., Bouillin J., Diallo H., Pelloquin R., Ayouba A., Kpamou C., Peeters M., Delaporte E., Etard J.-F., et Toure A.,
High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV),
Open Forum Infect Dis, vol. 9, no 5, p. ofac152, mai 2022. doi: 10.1093/ofid/ofac152.

Eloy P., Laouénan C., Beavogui A. H., Keita S., Manchon P., Etard J.-F., Sissoko D., Mentré F., et Malvy D.
High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea,
IDCases, vol. 27, p. e01412, 2022. doi: 10.1016/j.idcr.2022.e01412.

Nkuba A. N., Makiala S. M., Guichet E., Tshiminyi P. M., Bazitama Y. M., Yambayamba M. K., Kazenza B. M., Kabeya T. M., Matungulu E. B., Baketana L. K., Mitongo N. M., Thaurignac G., Leendertz F. H., Vanlerberghe V., Pelloquin R., Etard J.-F., Maman D., Mbala P. K., Ayouba A., Peeters M., Muyembe J.-J. T., Delaporte E., et Ahuka S. M.,
High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey,
Clin Infect Dis, vol. 74, no 5, p. 882‑890, mars 2022. doi: 10.1093/cid/ciab515.

Baron M., Soulié C., Lavolé A., Assoumou L., Abbar B., Fouquet B., Rousseau A., Veyri M., Samri A., Makinson A., Choquet S., Mazières J., Brosseau S., Autran B., Costagliola D., Katlama C., Cadranel J., Marcelin A.-G., Lambotte O., Spano J.-P., Guihot A., The French Cooperative Thoracic Intergroup Ifct Chiva-Investigators, et The Anrs Co OncoVIHAC Study Group,
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer,
Cells, vol. 11, no 6, p. 1015, mars 2022. doi: 10.3390/cells11061015.

Rojas Rojas T., Poizot-Martin I., Rey D., Duvivier C., Bani-Sadr F., Cabie A., Delobel P., Jacomet C., Allavena C., Ferry T., Pugliese P., Valantin M.-A., Lamaury I., Hustache-Matthieu L., Fresard A., Houyou T., Huleux T., Cheret A., Makinson A., Obry-Roguet V., Lions C., Carrieri M. P., Protopopescu C., et Dat’AIDS Study Group,
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France,
PLoS One, vol. 17, no 3, p. e0261069, 2022. doi: 10.1371/journal.pone.0261069.

Coulaud P.-J., Sow A., Sagaon-Teyssier L., Ndiaye K., Maradan G., Laurent C., Spire B., Vidal L., Kuaban C., Boyer S., et EVOLCam Group,
Individual and healthcare supply-related HIV transmission factors in HIV-positive patients enrolled in the antiretroviral treatment access program in the Centre and Littoral regions in Cameroon (ANRS-12288 EVOLCam survey),
PLoS One, vol. 17, no 4, p. e0266451, 2022. doi: 10.1371/journal.pone.0266451.

Chidoti V., De Nys H., Pinarello V., Mashura G., Missé D., Guerrini L., Pfukenyi D., Cappelle J., Chiweshe N., Ayouba A., Matope G., Peeters M., Gori E., Bourgarel M., et Liégeois F., Longitudinal Survey of Coronavirus Circulation and Diversity in Insectivorous Bat Colonies in Zimbabwe,
Viruses, vol. 14, no 4, p. 781, avr. 2022. doi: 10.3390/v14040781.

Bellet V., Roger F., Krasteva D., Gouveia T., Drakulovski P., Pottier C., et Bertout S.,
Multilocus sequence typing of strains from the Cryptococcus gattii species complex from different continents,
Mycoses, vol. 65, no 1, p. 88‑96, janv. 2022. doi: 10.1111/myc.13389.

MacGregor H., Leach M., Akello G., Sao Babawo L., Baluku M., Desclaux A., Grant C., Kamara F., Martineau F., Yei Mokuwa E., Parker M., Richards P., Sams K., Sow K., et Wilkinson A.,
Negotiating Intersecting Precarities: COVID-19, Pandemic Preparedness and Response in Africa,
Med Anthropol, vol. 41, no 1, p. 19‑33, janv. 2022. doi: 10.1080/01459740.2021.2015591.

Lajaunie R., Cuzin L., Palich R., Makinson A., Bani-Sadr F., Duvivier C., Arvieux C., Rey D., Poizot-Martin I., Delpierre C., Delobel P., Martin-Blondel G., et And The Dat’AIDS study group,
No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy,
HIV Med, vol. 23, no 3, p. 301‑306, mars 2022. doi: 10.1111/hiv.13168.

Sandie A. B., Molinari N., Wanjoya A., Kouanfack C., Laurent C., et Tchatchueng-Mbougua J. B.,
Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the « Stratall ANRS 12110 / ESTHER » trial,
Trials, vol. 23, no 1, p. 202, mars 2022. doi: 10.1186/s13063-022-06118-x.

Duval X., Taha M.-K., Lamaury I., Escaut L., Gueit I., Manchon P., Tubiana S., Hoen B., et COMBAT study group,
One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study,
Adv Ther, avr. 2022. doi: 10.1007/s12325-022-02149-7.

Schneider F. S., Molina L., Picot M.-C., L’Helgoualch N., Espeut J., Champigneux P., Alali M., Baptiste J., Cardeur L., Carniel C., Davy M., Dedisse D., Dubuc B., Fenech H., Foulongne V., Gaillard C. F., Galtier F., Makinson A., Marin G., Santos R. M., Morquin D., Ouedraogo A., Lejeune A. P., Quenot M., Keiflin P., Robles F. C., Rego C. R., Salvetat N., Trento C., Vetter D., Molina F., et Reynes J., Performances of rapid and connected salivary RT-LAMP diagnostic test for SARS-CoV-2 infection in ambulatory screening,
Sci Rep, vol. 12, no 1, p. 2843, févr. 2022. doi: 10.1038/s41598-022-04826-7.

Pansu N., Le Moing V., Poizot-Martin I., Joly V., Allavena C., Hocqueloux L., Duvivier C., Lourenco J., Jovelin T., Reynes J., et Makinson A.,
Pneumocystis jirovecii Pneumonia and Toxoplasmosis in PWH With HIV-Controlled Disease Treated for Solid Malignancies: A DAT’AIDS Study,
Open Forum Infect Dis, vol. 9, no 5, p. ofac109, mai 2022. doi: 10.1093/ofid/ofac109.

Watson-Jones D., Kavunga-Membo H., Grais R. F., Ahuka S., Roberts N., Edmunds W. J., Choi E. M., Roberts C. H., Edwards T., Camacho A., Lees S., Leyssen M., Spiessens B., Luhn K., Douoguih M., Hatchett R., Bausch D. G., Muyembe J.-J., et DRC-EB-001 protocol writing team,
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo,
BMJ Open, vol. 12, no 3, p. e055596, mars 2022. doi: 10.1136/bmjopen-2021-055596.

Eubanks A., Coulibaly B., Dembélé Keita B., Anoma C., Dah T. T. E., Mensah E., Maradan G., Bourrelly M., Mora M., Riegel L., Rojas Castro D., Yaya I., Spire B., Laurent C., Sagaon-Teyssier L., et and the COHMSM-PrEP Study Group,
Rate and Predictors of Ineffective HIV Protection in African Men Who Have Sex with Men Taking Pre-Exposure Prophylaxis,
AIDS Behav, avr. 2022. doi: 10.1007/s10461-022-03692-8.

Alfieri C., Egrot M., Desclaux A., Sams K., et CoMeSCov,
Recognising Italy’s mistakes in the public health response to COVID-19,
Lancet, vol. 399, no 10322, p. 357‑358, janv. 2022. doi: 10.1016/S0140-6736(21)02805-1.

Butler M. S., Gigante V., Sati H., Paulin S., Al-Sulaiman L., Rex J. H., Fernandes P., Arias C. A., Paul M., Thwaites G. E., Czaplewski L., Alm R. A., Lienhardt C., Spigelman M., Silver L. L., Ohmagari N., Kozlov R., Harbarth S., et Beyer P., Reply to Kaye and Belley,
« Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too! »,
Antimicrob Agents Chemother, p. e0022322, mars 2022. doi: 10.1128/aac.00223-22.

Veyrenche N., Pisoni A., Debiesse S., Bollore K., Bedin A.-S., Makinson A., Niel C., Alcocer-Cordellat C., Mondain A.-M., Le Moing V., Van de Perre P., et Tuaillon E.,
SARS-CoV-2 nucleocapsid urine antigen in hospitalized patients with Covid-19,
J Infect Dis, p. jiac073, mars 2022. doi: 10.1093/infdis/jiac073.

Bertout S., Gouveia T., Krasteva D., Pierru J., Pottier C., Bellet V., Arianiello E., Salipante F., Roger F., et Drakulovski P.,
Search for Cryptococcus neoformans/gattii Complexes and Related Genera (Filobasidium, Holtermanniella, Naganishia, Papiliotrema, Solicoccozyma, Vishniacozyma) spp. Biotope: Two Years Surveillance of Wild Avian Fauna in Southern France,
J Fungi (Basel), vol. 8, no 3, p. 227, févr. 2022. doi: 10.3390/jof8030227.

Raulino R., Thaurignac G., Keita A. K., Esteban A., Goumou S., Diallo R., Ndimbo-Kumugo S.-P., Ndong Bass I., Mbala Kingebeni P., Toure A., Delaporte E., Ahuka-Mundeke S., Muyembe Tamfum J.-J., Mpoudi-Ngole E., Peeters M., et Ayouba A.,
Seroprevalence of IgG Antibodies Against Multiple Arboviruses in Bats from Cameroon, Guinea, and the Democratic Republic of Congo,
Vector Borne Zoonotic Dis, vol. 22, no 4, p. 252‑262, avr. 2022. doi: 10.1089/vbz.2021.0076.

Debono B., Gerson C., Le Moing V., Houselstein T., Bougeard R., Lonjon G., et Lonjon N.,
Spine Surgery Infection, Litigation, and Financial Compensation: Analysis of 98 Claims Involving French Spine Surgeons Between 2015 and 2019,
World Neurosurg, vol. 159, p. e161‑e171, mars 2022. doi: 10.1016/j.wneu.2021.12.022.

Renault C., Veyrenche N., Mennechet F., Bedin A.-S., Routy J.-P., Van de Perre P., Reynes J., et Tuaillon E.,
Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs,
Front Immunol, vol. 13, p. 822576, 2022. doi: 10.3389/fimmu.2022.822576.

Marcy O., Goyet S., Borand L., Msellati P., Ung V., Tejiokem M., Do Chau G., Ateba-Ndongo F., Ouedraogo A. S., Dim B., Perez P., Asselineau J., Carcelain G., Blanche S., Delacourt C., et Godreuil S.,
Tuberculosis Diagnosis in HIV-Infected Children: Comparison of the 2012 and 2015 Clinical Case Definitions for Classification of Intrathoracic Tuberculosis Disease,
J Pediatric Infect Dis Soc, vol. 11, no 3, p. 108‑114, mars 2022. doi: 10.1093/jpids/piab113.

Leach M., MacGregor H., Akello G., Babawo L., Baluku M., Desclaux A., Grant C., Kamara F., Nyakoi M., Parker M., Richards P., Mokuwa E., Okello B., Sams K., et Sow K.,
Vaccine anxieties, vaccine preparedness: Perspectives from Africa in a Covid-19 era,
Soc Sci Med, vol. 298, p. 114826, févr. 2022. doi: 10.1016/j.socscimed.2022.114826.

Ky-Zerbo O., Desclaux A., Boye S., Vautier A., Rouveau N., Kouadio B. A., Fotso A. S., Pourette D., Maheu-Giroux M., Sow S., Camara C. S., Doumenc-Aïdara C., Keita A., Boily M. C., Silhol R., d’Elbée M., Bekelynck A., Gueye P. A., Diop P. M., Geoffroy O., Kamemba O. K., Diallo S., Ehui E., Ndour C. T., Larmarange J., et ATLAS team,
Willingness to use and distribute HIV self-test kits to clients and partners: A qualitative analysis of female sex workers’ collective opinion and attitude in Côte d’Ivoire, Mali, and Senegal,
Womens Health (Lond), vol. 18, p. 17455057221092268, déc. 2022. doi: 10.1177/17455057221092268.

Plenderleith L. J., Liu W., Li Y., Loy D. E., Mollison E., Connell J., Ayouba A., Esteban A., Peeters M., Sanz C. M., Morgan D. B., Wolfe N. D., Ulrich M., Sachse A., Calvignac-Spencer S., Leendertz F. H., Shaw G. M., Hahn B. H., et Sharp P. M.,
Zoonotic origin of the human malaria parasite Plasmodium malariae from African apes,
Nat Commun, vol. 13, no 1, p. 1868, avr. 2022. doi: 10.1038/s41467-022-29306-4.